Cargando…
Concordance of the 21-gene assay between core needle biopsy and resection specimens in early breast cancer patients
BACKGROUND: Adjuvant therapy decisions may be partly based on the results of a multigene quantitative reverse transcription-polymerase chain reaction (RT-PCR)-based assay: the 21-gene recurrence score (RS) test of resection specimens. When necessary, core needle biopsy (CNB) may be considered as a s...
Autores principales: | Qi, Peng, Yang, Yu, Bai, Qian-ming, Xue, Tian, Ren, Min, Yao, Qian-lan, Yang, Wen-tao, Zhou, Xiao-yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7804587/ https://www.ncbi.nlm.nih.gov/pubmed/33439420 http://dx.doi.org/10.1007/s10549-020-06075-6 |
Ejemplares similares
-
Comparison of protein expression between formalin-fixed core-cut biopsies and surgical excision specimens using a novel multiplex approach
por: Leal, Mariana Ferreira, et al.
Publicado: (2019) -
Patterns of biomarker expression in patients treated with primary endocrine therapy – a unique insight using core needle biopsy tissue microarray
por: Parks, R. M., et al.
Publicado: (2020) -
HER2 testing on core needle biopsy specimens from primary breast cancers: interobserver reproducibility and concordance with surgically resected specimens
por: Tsuda, Hitoshi, et al.
Publicado: (2010) -
Liquid biopsy assay for pulmonary adenocarcinoma using supernatants from core‐needle biopsy specimens
por: Kong, Fanlei, et al.
Publicado: (2022) -
Concordance of breast cancer biomarker testing in core needle biopsy and surgical specimens: A single institution experience
por: Slostad, Jessica A., et al.
Publicado: (2022)